Wire Stories

KKR Leads $200+ Million Growth Investment in Enterprise Identity Protection Leader Semperis

Semperis experiencing hyper-growth attributed to its solutions' unique capability to defend and recover from directory-based attacks combined with the company's…

4 years ago

BRIDGEWATER, N.J. & VADODARA, India--(BUSINESS WIRE)--#abreva--Cosette Pharmaceuticals, Inc ("Cosette"), in collaboration with Aleor Dermaceuticals, a wholly owned subsidiary of Alembic…

4 years ago

Gilat Satellite Networks to Present at the 2022 LD Micro Invitational Conference

Presentation will take place on Wednesday, June 8 at 2:30 PT PETAH TIKVA, Israel, May 24, 2022 (GLOBE NEWSWIRE) --…

4 years ago

MoneyLion and AEON Consortium Obtain Approval for Malaysian Digital Banking License

Digital Finance Leader MoneyLion Expands Enterprise Data and Technology Capabilities with AEON Group, One of Asia�s Largest Retailers and Financial…

4 years ago

LUXA BIO Announces First Participant Dosed in Phase 1/2a Clinical Trial of Adult RPESC-RPE-4W for Dry Age-related Macular Degeneration

FORT LEE, N.J.--(BUSINESS WIRE)--Luxa Biotechnology (LuxaBio), a joint venture between Y2 Solution Co. Ltd, Seoul, South Korea and the Neural…

4 years ago

Asia Pacific Dairy Flavors Markets Report, 2021-2022 & 2028: Enzyme-Modified Dairy Flavors Gaining Momentum & Opportunities in Surging Popularity of Clean Label and Organic Food Products – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Asia Pacific Dairy Flavors Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Flavor Profile, Form,…

4 years ago

India Construction Industry Report 2022: Industry is Expected to Register an Average Annual Growth of 6.2% During 2023-2026, Supported by Investment Under the ‘Pradhan Mantri Gati Shakti Master Plan’ – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "India Construction Market Size, Trends and Forecasts by Sector - Commercial, Industrial, Infrastructure, Energy and Utilities, Institutional and…

4 years ago

The confirmatory clinical, safety and efficacy study for AVT04, biosimilar candidate to Stelara� (ustekinumab) met its primary endpoint AVT04 (ustekinumab)…

4 years ago

Draganfly to Present at the H.C. Wainwright & Co. Global Investment Conference

Los Angeles, CA., May 24, 2022 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8) (�Draganfly� or the…

4 years ago

Draganfly to Present at the H.C. Wainwright & Co. Global Investment Conference

Los Angeles, CA., May 24, 2022 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8) (�Draganfly� or the…

4 years ago
Show more Posts
Show previous Posts